A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash - 12/08/17
Doi : 10.1016/j.jaad.2017.03.039
Viswanath R. Belum, MD a, Michael A. Marchetti, MD a, Stephen W. Dusza, DrPH, MPH a, Andrea Cercek, MD b, Nancy E. Kemeny, MD b, Mario E. Lacouture, MD a, ⁎ 
a Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
b Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
∗Reprint requests: Mario E. Lacouture, MD, Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 60th Street Outpatient Center, 16 East 60th St, Suite 407, room 4312, New York, NY 10022Dermatology ServiceDepartment of MedicineMemorial Sloan Kettering Cancer Center60th Street Outpatient Center, 16 East 60th St, Suite 407, room 4312New YorkNY10022
| Funding sources: Supported by Bristol-Myers Squibb (SK2013-0496) and the National Institutes of Health (P30 CA008748/CA/NCI). |
|
| Conflicts of interest: Dr Belum is supported by the “RJR” Oncodermatology Fund at Memorial Sloan Kettering Cancer Center. Dr Marchetti reports that he has served as a consultant to Ignyta. Dr Kemeny receives research funding from Amgen. Dr Cercek serves as an advisor to Bayer, Sandoz, and Amgen. Dr Lacouture is supported by the RJR Oncodermatology fund at Memorial Sloan Kettering Cancer Center, and reports that he is serving as a consultant to Quintiles, Boehringer Ingelheim, Genentech, Foamix, Infinity Pharmaceuticals, Janssen R&D, Novartis, and AstraZeneca pharmaceuticals. He has received research funding from Bristol-Myers Squibb, and Berg. Dr Dusza has nothing to disclose. |
|
| Previously presented: The background and study methods were presented as a poster at the American Society of Clinical Oncology in Chicago, Illinois, May 30, 2015. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 77 - N° 3
P. 577-579 - septembre 2017 Retour au numéro
Article précédent
- Circulating vitamin D–binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma: A case-control study
- Cristián Navarrete-Dechent, Constanza del Puerto, Montserrat Molgó, Sergio González, Guillermo Pérez-Mateluna, Pablo Uribe, Carlos A. Camargo, Arturo Borzutzky
- Correlation between HPV status via in situ hybridization testing on genital squamous papillomas and risk for cervical dysplasia or other anogenital HPV-related complications: A case-control study
- Michelle J. Duvall, Julie A. Maxon, Julia S. Lehman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?